← Back to MiPT

MiPT Stats & Data

Psychedelic Research-chemical

N-methyl-n-isopropyltryptamine

PubChem CID 29935323

NPS DataHub

MW216.33

FormulaC14H20N2

CAS96096-52-5

IUPACN-[2-(1H-indol-3-yl)ethyl]-N-methylpropan-2-amine

SMILESCC(C)N(C)CCc1cnc2ccccc12

InChIKeyKTQJVAJLJZIKKD-UHFFFAOYSA-N

Tryptamines; 2020/5.1 Indol-3-alkylamine; 2021/5.1 Indol-3-alkylamine; 2022/5.1 Indol-3-alkylamine

Chemical Class Phenethylamine

Psychoactive Class Psychedelic

Pharmacology

DrugBank

Toxicity

PsychonautWiki

The toxicity and long-term health effects of recreational MiPT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because MiPT is a research chemical with very little history of human usage. Anecdotal evidence from those who have tried MiPT suggests that there are no negative health effects attributed to simply trying the drug by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption. It is strongly recommended that one use harm reduction practices when using this drug.

Effect Profile

Curated + 22 Reports

Psychedelic 6.1

Strong visuals with mild auditory effects and body load, low headspace

Visual Intensity×3

103.8

Headspace Depth×3

35.4

Auditory Effects×1

Body Load / Somatic Effects×1

43.1

Catalog BlueLight

Based on reports from:

TiHKAL TiHKAL #47: MIPT Bluelight Big & Dandy Thread Erowid Experience Reports PsychonautWiki MiPT

Duration Timeline

Bluelight

Onset Comeup Peak Offset After Effects

Insufflated

0-1 minutes

3.0-5.0 hours

1.0-6.0 hours

Oral

30-45 minutes

2.0-5.0 hours

1.0-6.0 hours

Smoked

0-1 minutes

2.0-3.0 hours

1.0-6.0 hours

Tolerance & Pharmacokinetics

drugs.wiki

Tolerance Decay

Full tolerance 1h Half tolerance 10d Baseline ~14d

Cross-Tolerances

LSD

80% ●○○

Psilocybin

85% ●○○

Psilocin

85% ●○○

Mescaline

65% ●○○

DMT

85% ●○○

5-MeO-DMT

85% ●○○

2C-B

65% ●○○

2C-E

65% ●○○

Experience Report Analysis

Erowid BlueLight

14 Reports

1998–2021 Date Range

7 With Age Data

19 Effects Detected

Demographics

Gender Distribution

Age Distribution

Reports Over Time

Effect Analysis

Erowid + Bluelight

Effects aggregated from 22 experience reports (14 Erowid + 8 Bluelight)

22 Reports

59 Effects Detected

38 Positive

10 Adverse

11 Neutral

Effect Sentiment Distribution

Confidence Distribution

Positive Effects 38

Contentment 75.0% 75%

Music Enhancement 59.1% 89%

Emotional Openness 50.0% 80%

Introspection 45.4% 77%

Visual Trails 37.5% 73%

Analysis Enhancement 37.5% 78%

Brightness Enhancement 37.5% 78%

Color Enhancement 36.4% 80%

Stimulation 36.4% 80%

Euphoria 36.4% 82%

Empathy 36.4% 80%

Focus Enhancement 36.4% 72%

Body High 36.3% 81%

Tactile Enhancement 31.8% 75%

Tingling 25.0% 75%

Closed-Eye Visuals 25.0% 80%

Peripheral Imagery 25.0% 75%

Visual Sharpening 25.0% 75%

Awe 25.0% 75%

Appetite Increase 25.0% 72%

Adverse Effects 10

Anxiety 57.1% 70%

Nausea 36.4% 78%

Muscle Tension 21.4% 70%

Confusion 21.4% 70%

Headache 18.2% 70%

Vomiting 12.5% 70%

Body Load 12.5% 85%

Tension 12.5% 75%

Tremor 12.5% 75%

Dizziness 12.5% 65%

Real-World Dose Distribution

62K Doses

From 18 individual dose entries

Oral (n=12)

Median: 24.5mg 25th: 20.0mg 75th: 42.5mg 90th: 63.5mg

mg/kg median: 0.38 mg/kg 75th: 0.564

Form / Preparation

Most common forms and preparations reported

Redose Patterns

Redosing behavior across 10 reports

30.0% Redosed

1.4 Avg Doses

4m Median Interval

Read full reports on Erowid →

← Back to MiPT